GENOMMA LAB INTERNACIONAL ANNOUNCES FOURTEENTH DIVIDEND PAYMENT

Core Viewpoint - Genomma Lab Internacional has completed the payment of a cash dividend, reflecting its commitment to returning value to shareholders and its strong financial position [1][2]. Dividend Payment - The dividend is set at 0.20 Mexican pesos per share, totaling a distribution of 200 million pesos based on the outstanding shares of the company [2]. - The decision to pay this dividend was made by Genomma's Board of Directors, following the powers delegated at the Annual General Shareholders Meeting held on April 24, 2025, with intentions to make dividend payments on a quarterly basis [3]. Company Overview - Genomma Lab Internacional is recognized as one of the fastest-growing pharmaceutical and personal care product companies in Latin America, with a diverse range of premium branded products that lead in sales and market share [4]. - The company operates a robust business model characterized by innovative product development, consumer-oriented marketing, a wide retail distribution network, and a low-cost, flexible supply chain [4]. - Genomma Lab's shares are publicly traded on the Mexican Stock Exchange under the ticker "LABB" [4].